Accordingly, the siRNA-mediated depletion of 53BP1, DNA-PK or HDAC inhibition reduce the activation of the c-NHEJ pathway, promoting the rescue of stalled forks by HR and increasing the resistance of FA cells to MMC. The gene discussed is PRKDC; the disease is Friedreich ataxia.